Nahdi Medical Company
Sümbol: 4164.SR
SAU
133.8
SARTuruhind täna
19.4865
P/E suhe
0.0000
PEG suhe
17.39B
MRK Cap
- 0.04%
DIV tootlus
Nahdi Medical Company (4164-SR) Finantsaruanded
Bilanss
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 909.7 | 1076.3 | 401 | |||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.net-receivables | 0 | 433.5 | 130.2 | 140.3 | |||||
balance-sheet.row.inventory | 0 | 1409.4 | 1182.8 | 1116.5 | |||||
balance-sheet.row.other-current-assets | 0 | 6.2 | 174.3 | 141.6 | |||||
balance-sheet.row.total-current-assets | 0 | 2758.7 | 2563.6 | 1799.4 | |||||
balance-sheet.row.property-plant-equipment-net | 0 | 2307.1 | 2080.4 | 2213.3 | |||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.intangible-assets | 0 | 51.2 | 47.1 | 44.2 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 51.2 | 47.1 | 44.2 | |||||
balance-sheet.row.long-term-investments | 0 | 254.3 | 253.8 | 230.1 | |||||
balance-sheet.row.tax-assets | 0 | -254.3 | -253.8 | -230.1 | |||||
balance-sheet.row.other-non-current-assets | 0 | 254.3 | 253.8 | 230.1 | |||||
balance-sheet.row.total-non-current-assets | 0 | 2612.6 | 2381.3 | 2487.5 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 0 | 5371.3 | 4944.9 | 4286.9 | |||||
balance-sheet.row.account-payables | 0 | 894.3 | 637.2 | 484 | |||||
balance-sheet.row.short-term-debt | 0 | 304.2 | 375.9 | 367.4 | |||||
balance-sheet.row.tax-payables | 0 | 112.5 | 106.5 | 5.2 | |||||
balance-sheet.row.long-term-debt-total | 0 | 870.6 | 792.2 | 991.6 | |||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||
balance-sheet.row.other-current-liab | 0 | 26.8 | 156.4 | 126.1 | |||||
balance-sheet.row.total-non-current-liabilities | 0 | 1277.5 | 1193.1 | 1397.5 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 0 | 1174.8 | 1168.1 | 1359.1 | |||||
balance-sheet.row.total-liab | 0 | 2908.6 | 2701.5 | 2683.3 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.common-stock | 0 | 1300 | 1300 | 1300 | |||||
balance-sheet.row.retained-earnings | 0 | 794.4 | 663.8 | 112.6 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 368.4 | 279.6 | 191 | |||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-stockholders-equity | 0 | 2462.8 | 2243.4 | 1603.6 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 5371.3 | 4944.9 | 4286.9 | |||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-equity | 0 | 2462.8 | 2243.4 | 1603.6 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||
Total Investments | 0 | 254.3 | 253.8 | 230.1 | |||||
balance-sheet.row.total-debt | 0 | 1174.8 | 1168.1 | 1359.1 | |||||
balance-sheet.row.net-debt | 0 | 265.1 | 91.8 | 958 |
Rahavoogude aruanne
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 944.2 | 937.9 | 857.3 | |||||
cash-flows.row.depreciation-and-amortization | 0 | 618.1 | 596.6 | 571.5 | |||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||
cash-flows.row.change-in-working-capital | 0 | -155 | 52.5 | -13.4 | |||||
cash-flows.row.account-receivables | 0 | -38.2 | 6.9 | -47.7 | |||||
cash-flows.row.inventory | 0 | -214.6 | -127 | 85.9 | |||||
cash-flows.row.account-payables | 0 | 257.1 | 153.2 | 43.7 | |||||
cash-flows.row.other-working-capital | 0 | -159.4 | 19.4 | -95.3 | |||||
cash-flows.row.other-non-cash-items | 0 | -38.6 | 80.8 | -81.4 | |||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -384.5 | -275.2 | -306.5 | |||||
cash-flows.row.acquisitions-net | 0 | 0.3 | 0.1 | 7.1 | |||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -384.3 | -275.1 | -299.4 | |||||
cash-flows.row.debt-repayment | 0 | -435.7 | 0 | 0 | |||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||
cash-flows.row.dividends-paid | 0 | -715 | -300.3 | -1260 | |||||
cash-flows.row.other-financing-activites | 0 | -435.7 | -417 | -382.1 | |||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -1150.7 | -717.3 | -1642.1 | |||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -0.4 | -0.2 | 0 | |||||
cash-flows.row.net-change-in-cash | 0 | -166.6 | 675.3 | -607.5 | |||||
cash-flows.row.cash-at-end-of-period | 0 | 909.7 | 1076.3 | 401 | |||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1076.3 | 401 | 1008.5 | |||||
cash-flows.row.operating-cash-flow | 0 | 1368.7 | 1667.9 | 1334 | |||||
cash-flows.row.capital-expenditure | 0 | -384.5 | -275.2 | -306.5 | |||||
cash-flows.row.free-cash-flow | 0 | 984.2 | 1392.6 | 1027.5 |
Kasumiaruande rida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 8713.7 | 8616.2 | 8066.2 | |||||
income-statement-row.row.cost-of-revenue | 0 | 5191.5 | 5095.3 | 4761.5 | |||||
income-statement-row.row.gross-profit | 0 | 3522.2 | 3520.9 | 3304.7 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | -2561.2 | 4.5 | 10 | |||||
income-statement-row.row.operating-expenses | 0 | 2561.2 | 2535 | 2430.5 | |||||
income-statement-row.row.cost-and-expenses | 0 | 7752.7 | 7630.2 | 7192 | |||||
income-statement-row.row.interest-income | 0 | 56.8 | 12.1 | 3 | |||||
income-statement-row.row.interest-expense | 0 | 50.5 | 79.4 | 78.9 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | -961 | -64.7 | -62.3 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | -2561.2 | 4.5 | 10 | |||||
income-statement-row.row.total-operating-expenses | 0 | -961 | -64.7 | -62.3 | |||||
income-statement-row.row.interest-expense | 0 | 50.5 | 79.4 | 78.9 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | 618.1 | 596.6 | 571.5 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | 961 | 1002.6 | 919.6 | |||||
income-statement-row.row.income-before-tax | 0 | 944.2 | 937.9 | 857.3 | |||||
income-statement-row.row.income-tax-expense | 0 | 51.6 | 50.1 | 44.7 | |||||
income-statement-row.row.net-income | 0 | 892.6 | 887.8 | 812.5 |
Korduma kippuv küsimus
Mis on Nahdi Medical Company (4164.SR) koguvara?
Nahdi Medical Company (4164.SR) koguvara on 5371327292.000.
Mis on ettevõtte aastane tulu?
Aastane tulu on N/A.
Mis on ettevõtte kasumimarginaal?
Ettevõtte kasumimarginaal on 0.404.
Mis on ettevõtte vaba rahavoog?
Vaba rahavoog on 7.571.
Mis on ettevõtte puhaskasumimarginaal?
Puhaskasumimarginaal on 0.102.
Mis on ettevõtte kogutulu?
Kogutulu on 0.188.
Mis on Nahdi Medical Company (4164.SR) puhaskasum (puhaskasum)?
Puhaskasum (netotulu) on 892618140.000.
Kui suur on ettevõtte koguvõlg?
Koguvõlg on 1174755729.000.
Mis on tegevuskulude arv?
Tegevuskulud on 2561200000.000.
Milline on ettevõtte rahaline näitaja?
Ettevõtte raha on 0.000.